Ledger.Open graph →
SEC Form D · filed September 13, 2016

Lexaria Bioscience Corp

Offering
$109K
Sold
$109K
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
VANCOUVER, British Columbia, Canada
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (10)

Nicholas W. Baxter · Aberdeen, Scotland, United KingdomDirectorTed W. Mckechnie · Kitchener, Ontario, CanadaDirectorChristopher Bunka · Vancouver, British Columbia, CanadaExec · DirectorJohn M. Docherty · Vancouver, British Columbia, CanadaExec · DirectorJames Mccluney · San Jose, CADirectorNersi Nazari · San Jose, CADirectorChristopher J. Grasso · Hamilton, BermudaDirectorPatrick J. Mclaughlin · Hamilton, BermudaDirectorChristopher Bunka · Vancouver, British Columbia, CanadaExec · DirectorJohn M. Docherty · Vancouver, British Columbia, CanadaExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗